Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Toru KondoKarola S JeringC Jan Willem BorleffsRudolf A de BoerBrian Lee ClaggettAkshay S DesaiDan DobreanuCatherine M ViscoliAdrian F HernandezStefan P JanssensPardeep S JhundMikhail Naum KosiborodCarolyn Su Ping LamAnna Maria LangkildeFelipe A MartinezMagnus PeterssonPham Nguyen VinhMuthiah VaduganathanScott D SolomonJohn Joseph Valentine McMurrayPublished in: Circulation (2023)
gov; Unique identifier: NCT03619213.